NanoViricides (NNVC) Says Topical Drug Candidates for Treatment of Shingles Demonstrated Excellent Inhibition of Causative Virus

June 6, 2017 5:31 PM
NanoViricides, Inc., (NYSE: NNVC) (the "Company"), a pioneer in developing anti-viral nanomedicine drugs, reports that its topical drug candidates in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments

Next Articles